Macroeconomic Monitor
Home / Tags: progeneric policy

progeneric policy

About Novartis and corruption in healthcare

corruption in healthcare

What happens when a country has a limited public resource for healthcare that has no clear owner? Quite simply – it is distributed according to the needs of certain market players, and the entire system starts bidding for a piece of it. What happens? This is also the case with …

More »

Press Conference: Progeneric Policy for Lower Drug Costs

In connection with the deepening financial instability of the healthcare sector in Bulgaria, the experts from the EKIP have found a solution to the problem of the continuous increase in the costs of medicines of the NHIF. The analysis used data from the drug group of sartans (medicinal products for the treatment of arterial hypertension) for the period 2005-2016. …

More »